Patrick Haley
Corporate Officer/Principal bei EXELIXIS, INC.
Vermögen: 10 Mio $ am 31.03.2024
Profil
Patrick J.
Haley's current job is as the Executive Vice President-Commercial at Exelixis, Inc. His former job was as the Group Manager-Product at Genentech, Inc. from 2007 to 2010.
Mr. Haley completed his undergraduate degree at Duke University and holds an MBA from the Stephen M.
Ross School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
EXELIXIS, INC.
0,14% | 23.02.2024 | 419 053 ( 0,14% ) | 10 Mio $ | 31.03.2024 |
Aktive Positionen von Patrick Haley
Unternehmen | Position | Beginn |
---|---|---|
EXELIXIS, INC. | Corporate Officer/Principal | 01.11.2014 |
Ehemalige bekannte Positionen von Patrick Haley
Unternehmen | Position | Ende |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Patrick Haley
Duke University | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EXELIXIS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |